...
首页> 外文期刊>Japanese Journal of Pharmacology >BASAL STUDY ON EARLY DIAGNOSIS OF CADMIUM POISONING : CHANGE IN CARBONIC ANHYDRASE ACTIVITY
【24h】

BASAL STUDY ON EARLY DIAGNOSIS OF CADMIUM POISONING : CHANGE IN CARBONIC ANHYDRASE ACTIVITY

机译:早期诊断镉中毒的基础研究:碳酸酐酶活性的变化

获取原文

摘要

References(20) Cited-By(4) Cadmium chloride solution (contained 146 PPM of Cd) was administered to mice as drinking fluid for 90 days. Carbonic anhydrase activity was unaffected in blood, liver and kidneys 10 days after administration, however, enzymic activity was significantly reduced in all three organs thereafter. Catalase activity was unchanged until day 31, but was significantly reduced in all organs thereafter. Hemoglobin levels remained unchanged after 10 and 20 days administration, but were significantly reduced thereafter.Time course of response of carbonic anhydrase and catalase activities and blood hemoglobin level to CdCl2·21/2H2O in a dose of 10 mg/kg were examined at intervals ranging from 4 to 24 hr after a single s.c. injection. Carbonic anhydrase activity in liver, kidney and blood was significantly decreased every time, however, catalase activity in the above organs as well as the blood hemoglobin level did not change at any time.Whole-body retention of orally administered 115mCdCl2 with or without the carrier was examined at one week intervals for 30 days. Whole-body retention of 115mCd was significantly less in the carrier group than in the carrier-free group. Average Cd uptake for 30 days was 0.56 μg/day in the carrier-free group and 0.1 mg/day in the carrier group. Cd concentration in liver and kidneys on day 31 was 0.04 and 0.15 PPM respectively in the carrier-free group and each 24 PPM in the carrier group.
机译:参考文献(20)Cited-By(4)氯化镉溶液(含146 PPM的镉)作为小鼠的饮用液施用90天。给药后10天,血液,肝和肾脏中的碳酸酐酶活性未受影响,但是此后所有三个器官的酶活性均显着降低。到第31天为止,过氧化氢酶的活性没有改变,但是此后在所有器官中均明显降低。给药10天和20天后血红蛋白水平保持不变,但此后显着降低。以10 mg / kg的剂量间隔测定碳酸酐酶和过氧化氢酶活性的反应时间进程以及血红蛋白水平对CdCl2·21 / 2H2O的响应单次注射后4至24小时注射。肝脏,肾脏和血液中的碳酸酐酶活性每次都显着降低,但是上述器官中的过氧化氢酶活性以及血液中的血红蛋白水平在任何时候都没有变化.115mCdCl2口服或不服用载体的全身保留每隔一周检查一次,共30天。 115mCd的全身滞留率在无载体组明显低于无载体组。无载体组30天的平均Cd吸收量为0.56μg/天,而载体组为0.1 mg /天。无载体组第31天肝脏和肾脏中Cd的浓度分别为0.04和0.15 PPM,而载体组中分别为24 PPM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号